Home
Storia in 2 fonti
Pfizer just paid a lot of cash to catch up in the GLP race. Why its stock is higher
Pfizer is spending more than $7 billion to buy biotech Metsera to try to catch cup in the obesity drug market.
- ·
ft.com
Pfizer closes in on $7.3bn takeover of anti-obesity drugmaker Metsera
Deal would be the biggest by a large pharma company buying a foothold in the lucrative weight-loss drug market
- ·
cnbc.com
Pfizer just paid a lot of cash to catch up in the GLP race. Why its stock is higher
Pfizer is spending more than $7 billion to buy biotech Metsera to try to catch cup in the obesity drug market.